Cardlytics (NASDAQ:CDLX – Get Free Report) released its earnings results on Wednesday. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.10, FiscalAI reports. Cardlytics had a negative net margin of 44.12% and a negative return on equity of 235.70%. The firm had revenue of $56.10 million for the quarter, compared to the consensus estimate of $54.46 million.
Cardlytics Stock Up 8.5%
Shares of CDLX traded up $0.07 on Wednesday, hitting $0.90. 690,586 shares of the stock traded hands, compared to its average volume of 777,857. The company has a market capitalization of $48.65 million, a PE ratio of -0.43, a P/E/G ratio of 0.13 and a beta of 1.03. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.14 and a current ratio of 1.14. The business has a 50 day simple moving average of $1.07 and a 200 day simple moving average of $1.37. Cardlytics has a one year low of $0.75 and a one year high of $3.28.
Insider Transactions at Cardlytics
In other Cardlytics news, CEO Amit Gupta sold 52,049 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $0.90, for a total transaction of $46,844.10. Following the sale, the chief executive officer directly owned 704,803 shares in the company, valued at approximately $634,322.70. This trade represents a 6.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last quarter, insiders sold 117,875 shares of company stock valued at $113,022. Corporate insiders own 4.40% of the company’s stock.
Institutional Investors Weigh In On Cardlytics
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on CDLX. Wall Street Zen cut shares of Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Cardlytics in a research note on Monday, December 29th. Three analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $2.25.
Get Our Latest Research Report on CDLX
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Recommended Stories
- Five stocks we like better than Cardlytics
- CSE: ALEN.U is targeting a fast-growing digital wellness market
- New Copper-Rich “Kraken” Zone Discovered
- 1,500 Banks Just Handed the Fed Your Bank Account
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
